loading net worth // from filings
joaquin duato net worth // filing-anchoredas of 2026-02-15 · Form 4
Joaquin Duato Net Worth (2026)
Joaquin Duato is Chairman & CEO of Johnson & Johnson (JNJ). Most of a public-company CEO’s on-paper wealth is their stake in that company — anchored here on the number you can verify.
WHAT WE ESTIMATE
varies
Past cash compensation, sold shares, real estate, and other public holdings — estimable from records, but not exact.
WHAT CAN’T BE KNOWN
private
Private company stakes, trusts, cash, debts, and undisclosed assets. Anyone publishing these as a single number is guessing.
At a glance
| Company | Johnson & Johnson (JNJ) |
| Title | Chairman & CEO |
| Verified stake | $89M |
| Shares owned | 356,297 |
| Latest total pay | $33M breakdown → |
| Age | ~64 |
HOW THIS IS CALCULATED
We take the shares Joaquin Duato reports owning in their most recent SEC Form 4 and multiply by the latest share price. That gives a stake value you can check against the filing itself. Everything beyond that stake — real estate, private holdings, cash, past compensation — is estimated or simply not public, and we say so rather than roll it into one number.
BIOGRAPHY
Joaquin Duato was born in Spain in 1962 and raised in Valencia in a family full of healthcare workers, from a nurse mother to a pediatrician grandfather. He earned an MBA from ESADE in Barcelona and a master’s in international management in Arizona, then joined Johnson & Johnson’s Janssen pharmaceutical arm in Spain in 1989.
He moved to the United States in 2002 and rose to run the company’s worldwide pharmaceutical business, becoming vice chairman and then, in 2022, chief executive. He oversaw the spinoff of the consumer-health business into a separate company, Kenvue.
Duato is a hired executive and long-tenured company insider. His stake came from decades of compensation, the anchor of the figure here.
Born 1962 · University of Valencia; ESADE Business School (MBA)
CAREER
2022-presentChairman & CEO, Johnson & Johnson
2018-2021Vice Chairman, Executive Committee, Johnson & Johnson
NOTABLE
- Was awarded Spain Order of Civil Merit by King Felipe VI in 2023.
- Rose from a Johnson and Johnson pharmaceutical affiliate in Spain to lead the whole company and oversaw the Kenvue spinoff.
COMPENSATION HISTORY · from SEC proxy statements
| Fiscal year | Total pay |
|---|---|
| 2025 | $33M |
The richest CEOs
Ranked by filing-verified stake
The stake value is filing-derived and verifiable; any broader “net worth” is an estimate. Photo: Stephanie Diani, CC BY-SA 4.0 (Wikimedia Commons). Share counts are the latest reported on SEC filings and change as the executive trades; the price is the last close, so the stake value moves with the market. This is not an official or complete accounting of anyone’s wealth. Educational only — not investment advice.
